Cargando…

Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma

Background: Increasing evidence has demonstrated the clinical importance of hypoxia and its related factors in lung adenocarcinoma (LUAD). Methods: RNA-seq datasets from The Cancer Genome Atlas (TCGA) were analyzed using the differentially expressed genes in hypoxia pathway by the Least Absolute Shr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qirui, Chen, Shuo, Wang, Jing, Zhao, Yan, Ye, Xin, Fu, Yili, Liu, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085621/ https://www.ncbi.nlm.nih.gov/pubmed/36971680 http://dx.doi.org/10.18632/aging.204613

Ejemplares similares

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2022)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
por: Zhou, Chang-shuai, et al.
Publicado: (2021)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
por: Zhu, Qianjun, et al.
Publicado: (2023)

Construction and validation of an immunity-related prognostic signature for breast cancer
por: Zhu, Tao, et al.
Publicado: (2020)

Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival
por: Xu, Jingmin, et al.
Publicado: (2022)

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
por: Yang, Jing, et al.
Publicado: (2022)

Development and validation of a hypoxia-associated signature for lung adenocarcinoma
por: Lane, Brian, et al.
Publicado: (2022)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
por: Ren, Min, et al.
Publicado: (2023)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

Hypoxia-Related Signature Is a Prognostic Biomarker of Pancreatic Cancer
por: Zhang, Jing-jing, et al.
Publicado: (2022)

Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients
por: Liu, Yunxun, et al.
Publicado: (2023)

Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma
por: Hui, Hongliang, et al.
Publicado: (2023)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

Development and validation of a hypoxia-related prognostic signature for breast cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
por: Li, Baihui, et al.
Publicado: (2021)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
por: Lu, Lina, et al.
Publicado: (2023)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
por: Ma, Yibo, et al.
Publicado: (2023)

Immune characteristics analysis and construction of a four-gene prognostic signature for lung adenocarcinoma based on estrogen reactivity
por: Wang, Yangwei, et al.
Publicado: (2023)

Construction of a Novel MYC-Associated ceRNA Regulatory Network to Identify Prognostic Biomarkers in Colon Adenocarcinoma
por: Xin, Rui, et al.
Publicado: (2022)

Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma
por: Peng, Yue-ling, et al.
Publicado: (2023)

Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
por: Wen, Ya-Dan, et al.
Publicado: (2021)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32j3qbtp0rd5j7uo1ss1p9nobg